| Literature DB >> 35619191 |
Yi-Tian Fu1, Chaoqun Yao2, Yuan-Ping Deng1, Hany M Elsheikha3, Renfu Shao4, Xing-Quan Zhu5,6, Guo-Hua Liu7.
Abstract
BACKGROUND: Human pediculosis is caused by hematophagous lice, which are transmitted between individuals via direct and/or indirect contact. Despite the public health importance of louse infestation, information concerning the global burden of pediculosis and the epidemiological landscape of louse-borne diseases is limited. The aim of this review was to summarize the biology, epidemiology, diagnosis, and control of lice infestation in humans. We also discussed the latest advances in molecular taxonomy and molecular genetics of lice.Entities:
Keywords: Human lice; Omics technology; Pediculosis; Phylogenetics; Public health
Mesh:
Substances:
Year: 2022 PMID: 35619191 PMCID: PMC9134731 DOI: 10.1186/s40249-022-00986-w
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 10.485
Fig. 1Flow diagram of the scoping review process
Fig. 2Human lice
Fig. 3Phylogenetic analysis of the mitochondrial cytb sequences of Pediculus humanus from different geographical regions and countries. The sequences of cytb were aligned using MAFFT 7.245, and neighbor-joining (NJ) phylogenetic tree was constructed using MEGA 6, with the GTR + I + G substitution model selected by jModelTest 2.1.7. Bootstrap frequency (Bf) was calculated using 100 bootstrap replicates. Pediculus schaeffi was used as an outgroup. Scale bar denotes nucleotide substitutions per site
Worldwide distribution of human louse Pediculus humanus clades
| Clade | Ecotype | Continent | Country/region |
|---|---|---|---|
| A | All over the world | All over the world | |
| B | Africa | Algeria, South Africa | |
| Asia | Israel, Saudi Arabia | ||
| Australia | Australia | ||
| Europe | Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Finland, Germany, Greece, Hungary, Iceland, Italy, Macedonia, Montenegro, Netherlands, Portugal, Romania, Serbia, Slovakia, Slovenia, Spanish, Sweden, Switzerland, United Kingdom | ||
| Latin America | Belize, Costa Rica, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, Salvador | ||
| North America | Canada, The United States | ||
| C | Africa | Ethiopia, Senegal, the Republic of Congo | |
| Asia | Nepal, Pakistan, Thailand | ||
| Europe | France | ||
| D | Africa | Ethiopia, the Democratic Republic of Congo, the Republic of Congo, Zimbabwe | |
| E | Africa | Guinea, Mali, Senegal | |
| F | Latin America | Argentina, Mexico, French Guiana |
Fig. 4Life cycle of human head louse, Pediculus humanus capitis.
Adapted from Centers for Disease Control and Prevention (CDC) DPDx website (https://www.cdc.gov/parasites/lice/head/biology.html)
Pathogens associated with Pediculus humanus and Pthirus pubis lice
| Head lice | Body lice | Pubic lice | |
|---|---|---|---|
| DNA detection | |||
| Experimental model | No reported cases | ||
| Disease transmission | No reported cases | Trench fever Louse-borne relapsing fever Epidemic typhus | No reported cases |
Topical insecticides and/or medications used in the management of head louse infestation
| Insecticide | Drug class | Mechanism of action | Application | Efficacy % | Side effects | References |
|---|---|---|---|---|---|---|
| Permethrin | Synthetic pyrethroid | Inhibits sodium ion influx | Infants (> 2 months) and adults | 20–30% eggs remained | Irritation and allergy | [ |
| Piperonyl butoxide | Benzodioxoles | Inhibits the metabolism of pyrethrin and increases its persistence and effectiveness against lice | Children (> 2 years) and adults | 78–83% (combined with permethrin) | Dermatological symptoms | [ |
| Dimethicone | Polydimethylsiloxane | Physical action | Children (> 1 year) and adults | > 80% (for pyrethroid-resistant) | Dermatological symptoms | [ |
| Xeglyze | Abametapir | Inhibits metalloproteinase | Infants (> 6 months) and adults | Prevented 100% of eggs from hatching | Scalp erythema, rash and burning sensation | [ |
| Lotilaner | Isoxazoline | Inhibitsγ-aminobutyric acid-gated chloride channels | School children and older | 100% death rate for adult lice with 10 and 100 μmol/L after 3 h exposure | Dermatological symptoms | [ |
| Malathion (0.5%) | Organophosphate | Inhibits cholinesterase and acute toxicity | Children (> 6 years) | 82–100% | Scalp dryness, irritation, dandruff | [ |
| Spinosad | Aminoglycosides | Alters function of acetylcholine and GABA-gated ion channels | Children (> 4 years) | 68–87% | Breathing problems | [ |
| Ivermectin 5% | Macrocyclic lactone | Activates glutamate-gated chloride channels in nerve and muscle cells | Children (> 6 months) and adults | 74% | Eye irritation and skin-burning sensation | [ |
| Oral ivermectin | Macrocyclic lactone | Activates glutamate-gated chloride channels in nerve and muscle cells | Children aged > 5 years and/or weighing > 15 kg and adults | 77–95% | Impetigo, nausea or vomiting, gastroenteritis, and convulsion | [ |
| Benzyl alcohol 5% | Aromatic alcohol | Closing respiratory spiracles and suffocation | Infants (> 6 months) and adults | 75–76% | Breathing problems | [ |